Commitments and Contingencies - Additional Information (Detail) $ in Millions |
Jun. 04, 2024
item
|
Jul. 12, 2019
USD ($)
|
|---|---|---|
| Derivative Action | ||
| Commitments And Contingencies [Line Items] | ||
| Number of complaints | 1 | |
| Number of company executives named as defendants in class action complaint | 3 | |
| Number of company board members named as defendants in class action complaint | 8 | |
| Spitfire Pharma, Inc. [Member] | Sales Milestones [Member] | ||
| Commitments And Contingencies [Line Items] | ||
| Estimated future contingent consideration | $ | $ 80.0 | |
| License agreement term | 10 years |
| X | ||||||||||
- Definition Business acquisition term of license agreement. No definition available.
|
| X | ||||||||||
- Definition Commitments and contingencies. No definition available.
|
| X | ||||||||||
- Definition Number of company board members named as defendant in class action complaint filed against the company in federal district court. No definition available.
|
| X | ||||||||||
- Definition Number of company executives named as defendant in class action complaint filed against the company in federal district court. No definition available.
|
| X | ||||||||||
- Definition Number of complaints filed against the company in federal district court. No definition available.
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|